Europe: Medicaments Containing Hormones Market 2024

Medicaments Containing Hormones Market Size in Europe

In 2022, the Europe medicaments containing hormones market decreased by X% to $X, falling for the second year in a row after two years of growth. Over the period under review, consumption, however, recorded a mild downturn. The level of consumption peaked at $X in 2020; however, from 2021 to 2022, consumption failed to regain momentum.

Medicaments Containing Hormones Production in Europe

In value terms, medicaments containing hormones production reduced slightly to $X in 2022 estimated in export price. Over the period under review, production, however, showed a slight downturn. The most prominent rate of growth was recorded in 2015 when the production volume increased by X%. The level of production peaked at $X in 2012; however, from 2013 to 2022, production remained at a lower figure.

Medicaments Containing Hormones Exports

Exports in Europe

In 2022, exports of medicaments containing hormones but not antibiotics in Europe surged to X tons, with an increase of X% against 2021. Overall, exports enjoyed significant growth. As a result, the exports attained the peak and are likely to continue growth in the immediate term.

In value terms, medicaments containing hormones exports skyrocketed to $X in 2022. Over the period under review, exports, however, continue to indicate a relatively flat trend pattern. Over the period under review, the exports hit record highs at $X in 2013; however, from 2014 to 2022, the exports stood at a somewhat lower figure.

Exports by Country

The shipments of the one major exporters of medicaments containing hormones but not antibiotics, namely Ireland, represented more than two-thirds of total export.

Ireland was also the fastest-growing in terms of the medicaments containing hormones but not antibiotics exports, with a CAGR of X% from 2012 to 2022. Ireland (X p.p.) significantly strengthened its position in terms of the total exports, while the shares of the other countries remained relatively stable throughout the analyzed period.

In Ireland, medicaments containing hormones exports increased at an average annual rate of X% over the period from 2012-2022.

Export Prices by Country

In 2022, the export price in Europe amounted to $X per ton, which is down by X% against the previous year. Overall, the export price faced a precipitous shrinkage. The most prominent rate of growth was recorded in 2021 when the export price increased by X% against the previous year. The level of export peaked at $X per ton in 2012; however, from 2013 to 2022, the export prices stood at a somewhat lower figure.

As there is only one major export destination, the average price level is determined by prices for Ireland.

From 2012 to 2022, the rate of growth in terms of prices for Ireland amounted to X% per year.

Medicaments Containing Hormones Imports

Imports in Europe

In 2022, overseas purchases of medicaments containing hormones but not antibiotics increased by X% to X tons for the first time since 2017, thus ending a four-year declining trend. The total import volume increased at an average annual rate of X% over the period from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. As a result, imports reached the peak and are likely to continue growth in the immediate term.

In value terms, medicaments containing hormones imports soared to $X in 2022. Overall, imports posted a strong increase. The growth pace was the most rapid in 2020 when imports increased by X% against the previous year. As a result, imports reached the peak of $X. From 2021 to 2022, the growth of imports failed to regain momentum.

Imports by Country

The Netherlands represented the main importing country with an import of about X tons, which recorded X% of total imports. Spain (X tons) took an X% share (based on physical terms) of total imports, which put it in second place, followed by Denmark (X%), Hungary (X%) and Poland (X%). The following importers - Bulgaria (X tons) and the UK (X tons) - together made up X% of total imports.

Imports into the Netherlands increased at an average annual rate of X% from 2012 to 2022. At the same time, Bulgaria (X%), Poland (X%), Denmark (X%) and Hungary (X%) displayed positive paces of growth. Moreover, Bulgaria emerged as the fastest-growing importer imported in Europe, with a CAGR of X% from 2012-2022. By contrast, Spain (X%) and the UK (X%) illustrated a downward trend over the same period. While the share of the Netherlands (X p.p.), Denmark (X p.p.), Poland (X p.p.), Hungary (X p.p.) and Bulgaria (X p.p.) increased significantly in terms of the total imports from 2012-2022, the share of the UK (X p.p.) and Spain (X p.p.) displayed negative dynamics.

In value terms, Denmark ($X) constitutes the largest market for imported medicaments containing hormones but not antibiotics in Europe, comprising X% of total imports. The second position in the ranking was held by the Netherlands ($X), with a X% share of total imports. It was followed by Poland, with a X% share.

In Denmark, medicaments containing hormones imports increased at an average annual rate of X% over the period from 2012-2022. The remaining importing countries recorded the following average annual rates of imports growth: the Netherlands (X% per year) and Poland (X% per year).

Import Prices by Country

In 2022, the import price in Europe amounted to $X per ton, with a decrease of X% against the previous year. Over the period under review, the import price, however, enjoyed a mild increase. The most prominent rate of growth was recorded in 2020 when the import price increased by X%. As a result, import price reached the peak level of $X per ton. From 2021 to 2022, the import prices remained at a somewhat lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was Denmark ($X per ton), while Spain ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Poland (X%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform